MANILA – The Bureau of Permits Manila warned businesses not to sell “Ashley Shine Beauty Products”, especially if the items are labeled with “Manila, Province of China”.
In a letter issued on Thursday, Permits head Levi Facundo said those who will be caught selling or distributing the said products may be served with a closure or a cease and desist order.
He said the products did not pass the Food and Drugs Administration’s verification process.
“Ito ay matapos mapag-alamanan ng Food and Drugs [Administration] na ang nasabing produkto ay hindi dumaan sa “verification process” at walang nailabas na “proper authorization” para ito ay kilalanin na isang produktong pampaganda (this after we learned that the said product did not pass the FDA’s verification process and that there is no proper authorization that recognizes it as a beauty product)”, Facundo said.
Facundo added that using the said product may cause side effects and pose potential health hazards to the consumers.
“Pursuant to Republic Act 9711, otherwise known as the Food and Drug Administration Act of 2009, the manufacture, importation, exportation, sale, offering for sale, distribution, transfer, non-consumer use, promotion, advertising or sponsorship of health products without the proper authorization from FDA is prohibited. Accordingly, because of unnotified cosmetic products that have not gone through the verification process of the FDA, the agency cannot guarantee their quality and safety,” the letter read.
The packaging labels of Ashley Shine Beauty products have been misbranded when they claim that Manila is a province of China.
Ashley Shine Beauty Products is manufactured for and by Elegant Fumes Beauty Products Inc. with an office in Binondo, Manila.
Facundo warned business establishments not to use, sell, or distribute the said product until they are covered by the appropriate authorization, otherwise regulatory actions and sanctions shall be strictly pursued.
The general public is also advised to be vigilant against cosmetic products that might not be duly registered with and approved by the FDA. (PNA)